Michael Ritt Jaff
DO, FACP, FACC
Dr. Michael Ritt Jaff
Vascular Medicine Specialist
Innovator
Newton-Wellesley Hospital
Michael R. Jaff, DO, professor of medicine at Harvard Medical School, became the President of Newton-Wellesley Hospital in October 2016. Prior to that, Dr. Jaff was the inaugural Paul and Phyllis Fireman Endowed Chair of Vascular Medicine and Medical Director of the Fireman Vascular Center at the Massachusetts General Hospital. He remains an active clinical consultant in all aspects of vascular medicine, including peripheral artery disease, venous thromboembolic disease, aneurysmal diseases, and all diagnostic strategies in vascular medicine.
He is the founder of VasCore, the Vascular Ultrasound Core Laboratory, the largest of its’ kind in the United States. VasCore has participated in trial design and independent analysis of vascular laboratory images for over 180 prospective multicenter peripheral vascular device and pharmaceutical trials across 66 countries.
Dr. Jaff has published extensively in the field of Vascular Medicine with over 210 peer-reviewed publications and 9 textbooks, is the Past-President of the Society for Vascular Medicine and Biology, and was the first physician to have received the designation as Master of the Society for Vascular Medicine. He is a Fellow of the American College of Physicians, American College of Cardiology, the American Heart Association, and the Society for Cardiovascular Angiography and Intervention, and is a registered physician in vascular interpretation (RPVI).
In November 2011, Dr. Jaff became an alumnus of Harvard Business School after completing the General Management Program.
| Organization | Role | Purpose | Compensation |
| Abbott | Consulting Fees | ||
| American Orthotic & Prosthetic Association | Member | Medical Advisory Board | Consulting Fees |
| Cardinal Health | Consultant | Improved vascular closure devices. | Consulting Fees |
| CBSET | Board of Directors Member | Not-for-profit basic and translational science facility assisting in the development of lifesaving therapies in cardiovascular medicine. | Consulting Fees |
| IC Sciences | Investor | Personal investment in business. | Non-compensated |
| Jana Care | Investor | Personal investment in business. | Non-compensated |
| MC10 | Investor | Personal investment in business. | Non-compensated |
| Medtronic | Consultant | Consulting | Consulting Fees |
| Micell | Scientific Advisory Board Member | Development of novel drug-eluting stents. | Equity |
| Northwind | Investor | Personal investment in business. | Non-compensated |
| Novella | DSMB Member | Provide oversight of BiO2 Medical study pursuant to BiO2's Study Protocol QD-230 Rev. B | Consulting Fees |
| PQ Bypass | Investor | Personal investment in business. | Non-compensated |
| Primacea | Board of Directors Chair | Ethical collaborations between physicians, hospitals and the medical industry. | Non-compensated |
| Primacea | Investor | Personal investment in business. | Non-compensated |
| Sano V | Investor | Personal investment in business. | Non-compensated |
| SANOFI US SERVICES | Consultant | Consulting | Consulting Fees |
| Silk Road | Consultant | Consulting | Consulting Fees |
| Valiant | Equity | ||
| Vascular Therapies | Investor | Personal investment in business. | Non-compensated |
| VIVA | President-Elect and Board Member | Education for physicians and healthcare professionals dedicated to treating patients with vascular diseases. | Consulting Fees |
| Volcano | Consultant | Consulting Fees | |
| Volcano | Consultant | Consulting | Consulting Fees |
Publication (06/18/2014)
Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. Chatterjee S, Chakraborty A, Weinberg I, Kadakia M, Wilensky RL, Sardar P, Kumbhani DJ, Mukherjee D, Jaff MR, Giri J. JAMA. 2014 Jun 18;311(23):2414-21. doi: 10.1001/jama.2014.5990. PMID: 24938564
Publication (04/30/2014)
Economic analysis of endovascular interventions for femoropopliteal arterial disease: A systematic review and budget impact model for the United States and Germany. Pietzsch JB, Geisler BP, Garner AM, Zeller T, Jaff MR. Catheter Cardiovasc Interv. 2014 Apr 30. doi: 10.1002/ccd.25536. [Epub ahead of print] PMID: 24782424
Publication (03/01/2014)
Blood pressure response to renal artery stenting in 901 patients from five prospective multicenter FDA-approved trials. Weinberg I, Keyes MJ, Giri J, Rogers KR, Olin JW, White CJ, Jaff MR. Catheter Cardiovasc Interv. 2014 Mar 1;83(4):603-9. doi: 10.1002/ccd.25263. Epub 2013 Nov 9. PMID: 24307609.
Clinical Role (01/10/2014)
First recipient of an endowed chair in Vascular Medicine at Massachusetts General Hospital (Paul and Phyllis Fireman Chair in Vascular Medicine).
Michael R. Jaff, DO is Professor of Medicine at Harvard Medical School, Chair of the MGH Institute for Heart, Vascular, and Stroke Care, Medical Director of the Vascular Center, and the Medical Director of the Vascular Diagnostic Laboratory at the Massachusetts General Hospital.
Dr. Jaff is an active clinical consultant in all aspects of vascular medicine, including peripheral arterial disease, venous thromboembolic disease, aneurysmal diseases, and all diagnostic strategies in vascular medicine.
He is the founder and Medical Director of the Vascular Ultrasound Core Laboratory, the largest of its’ kind in the United States. The Vascular Ultrasound Core Laboratory has participated in trial design and independent analysis of vascular laboratory images for over 100 prospective multicenter trials.
Dr. Jaff has published extensively in the field of Vascular Medicine with over 160 peer-reviewed publications and 9 textbooks, is the Past-President of the Society for Vascular Medicine and Biology, and was the first physician to have received the designation as Master of the Society for Vascular Medicine. He is a Fellow of the American College of Physicians, American College of Cardiology, the American Heart Association, and the Society for Cardiovascular Angiography and Intervention, and is a registered physician in vascular interpretation (RPVI).
Dr. Jaff received an honorary Doctorate of Science from A.T. Still University School of Medicine in 2008, and received the “Leaders in Vascular Education” award at the annual Vascular Interventional Advances (VIVA) meeting held in Las Vegas, Nevada in October 2010. In November 2011, Dr. Jaff became an alumnus of Harvard Business School. In January 2014, Dr. Jaff was named the first incumbent of the Paul and Phyllis Fireman Endowed Chair in Vascular Medicine.